SIRT3 and chronic kidney disease: In the context of angiotensin II-induced nephropathy, SIRT3 exhibits nephroprotective by counteracting iron overload and inhibiting NADPH oxidase-mediated ROS overproduction, ultimately attenuating renal fibrogenesis and delaying CKD progression310.